Clin2
NCT07839338Possibly a fitNot yet recruiting

Comparing oral ketamine and midazolam for depression

Major Depressive Episode

Part of Mental health clinical trials.

This trial tests whether two oral medications, ketamine and midazolam, can help treat major depression when taken by mouth. It aims to compare how well each drug works in reducing depressive symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
220 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are an adult (18 or older) with moderate to severe depression or bipolar depression.
  • Your symptoms must be severe enough to score at least 20 on a standard depression rating scale (a doctor will check this).
  • You cannot have OCD, intellectual disability, or substance dependence (except nicotine).
  • You cannot be receiving neuromodulation treatments like ECT or TMS.
  • You cannot have active suicidal thoughts with a plan in the last 3 days if you are an outpatient.
  • You must not have an abnormal ECG, uncontrolled high blood pressure, or be pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06752759Recruiting· Phase 3
Ketamine mist for depression

This trial tests if a ketamine mist you breathe in can help treat moderate to severe depression. It is for adults who are not helped enough by other treatments.

Brooklyn, New York
NCT07683988Not yet recruiting· Phase 1
Ketamine for treatment-resistant depression

This study tests whether ketamine, given as a liquid under the tongue or swallowed, can help people with depression that hasn't improved with at least two other antidepressants. It aims to see if this treatment is safe and effective.

NCT06090422Recruiting· Phase 1/Phase 2
Ketamine for depression and alcohol use disorder

This trial tests if ketamine can help people who have both depression and alcohol use disorder. You must be currently sober, have at least moderate depression, and be admitted to the hospital for addiction treatment.

Tromsø
NCT05327699Recruiting· Early Phase 1
Ketamine study for depression with reduced pleasure

This early-phase study tests whether ketamine can help people with major depression who have trouble feeling pleasure. It also studies how the brain may change in response to stress, to better understand who might respond to treatment.

Atlanta, Georgia
NCT06788249Recruiting· Early Phase 1
Ketamine for treatment-resistant depression brain study

This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.

Philadelphia, Pennsylvania
NCT06559826Recruiting· Phase 2
Ketamine therapy with or without talk for depression

This study compares ketamine alone to ketamine combined with psychotherapy for treating depression. It may help if you have moderate to severe depression and want to see if adding talk therapy improves results.

New York, New York

Hear when a new Major Depressive Episode trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.